Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
05/14/2024 |
PubMed |
The beta-subunit of tryptophan synthase is a latent tyrosine synthase. |
|
05/13/2024 |
PubMed |
Superhydrophobic MOF/polymer composite with hierarchical porosity for boosting catalytic performance in an humid environment. |
|
04/01/2024 |
PubMed |
Proteomic profiling of Arabidopsis G-protein beta subunit AGB1 mutant under salt stress. |